Herpes simplex virus: Difference between revisions
From IDWiki
(→: Initial) |
(→: filled out many more presentations) |
||
Line 30: | Line 30: | ||
== Clinical Presentation == |
== Clinical Presentation == |
||
=== Primary infection === |
|||
* Incubation period usually within 5 days for primary infection |
* Incubation period usually within 5 days for primary infection |
||
* Mucocutaneous lesiosn may become secondarily infected |
* Mucocutaneous lesiosn may become secondarily infected |
||
=== Orofacial infection === |
==== Orofacial infection ==== |
||
* Most common sites of primary infection are gingivostomatitis and pharyngitis |
* Most common sites of primary infection are gingivostomatitis and pharyngitis |
||
** Includes lesions on hard and soft palate, gingiva, tongue, lips, and face |
** Includes lesions on hard and soft palate, gingiva, tongue, lips, and face |
||
Line 41: | Line 43: | ||
* Can cause a [[Bell palsy]] |
* Can cause a [[Bell palsy]] |
||
=== Genital infection === |
==== Genital infection ==== |
||
* Genital lesions typically last 10 to 12 days, especially with first episode |
* Genital lesions typically last 10 to 12 days, especially with first episode |
||
** Often widely spaced bilateral lesions |
** Often widely spaced bilateral lesions |
||
Line 52: | Line 54: | ||
* 12-month recurrence rate is up to 90% for HSV-2 and 55% for HSV-1 |
* 12-month recurrence rate is up to 90% for HSV-2 and 55% for HSV-1 |
||
=== Neurological complications === |
===== Neurological complications ===== |
||
* These can include aseptic meningitis, transverse myelitis, and sacral radiculopathy |
* These can include aseptic meningitis, transverse myelitis, and sacral radiculopathy |
||
* Typically occur in conjunction with first episode of genital HSV-2 infection |
* Typically occur in conjunction with first episode of genital HSV-2 infection |
||
* '''Aseptic meningitis''' |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
==== |
===== Pelvic inflammatory disease ===== |
||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
=== Pelvic inflammatory disease === |
|||
* Rare cause of PID, possibly representing dual infection with a typical bacterial copathogen |
* Rare cause of PID, possibly representing dual infection with a typical bacterial copathogen |
||
=== Disseminated disease === |
===== Disseminated disease ===== |
||
* Rarely can disseminate |
* Rarely can disseminate |
||
* Can be cutaneous, with concurrent meningitis, hepatitis, and pneumonitis |
* Can be cutaneous, with concurrent meningitis, hepatitis, and pneumonitis |
||
* Can also involve monocular arthritis, thrombocytopenia, adrenal necrosis, and myoglobinuria |
* Can also involve monocular arthritis, thrombocytopenia, adrenal necrosis, and myoglobinuria |
||
* Patient factors include primary genital HSV in pregnancy, reactivation of genital HSV in a patient with cellular immunocompromise |
* Patient factors include primary genital HSV in pregnancy, reactivation of genital HSV in a patient with cellular immunocompromise |
||
=== Reactivation === |
|||
* Typically localized to a single mucocutaneous area |
|||
* Symptoms are usually more minor than first-episode or primary infection, and include itching and pain |
|||
** Lesions may be atypical, with fissures and unusual ulcers |
|||
** May be subclinical, with intermittent viral shedding |
|||
** May be preceded by a prodrome of tingling up to 2 days |
|||
* Average duration of an episode of reactivation orolabial herpes is 5 days |
|||
* HSV-1 reactivates more frequently around mouth, and HSV-2 in genitals |
|||
* Frequency |
|||
** HSV-2 reactivates on average 4 to 5 times annually, with a gradual decrease over time |
|||
=== Herpetic whitlow === |
|||
* HSV infection of the finger, with acute onset swelling, pain, and tenderness with vesicles |
|||
* Also fever and regional lymphadenopathy |
|||
* Can be either acquired from parson-to-person exposure or through autoinoculation |
|||
* Higher rates in healtcare settins |
|||
=== Herpes gladiatorum === |
|||
* Herpes simplex infection essentially anywhere on the body (chest, ears, face, and hands) associated with wrestling |
|||
=== Ocular herpes === |
|||
* '''Keratitis''', which presents with pain, blurred vision, chemosis, conjunctivitis, and corneal lesions |
|||
* May also cause blepharitis and conjunctivitis |
|||
* May cause '''chorioretinitis''' in infants and immunocompromised |
|||
* '''Acute necrotizing retinitis''' |
|||
** Presents with painless vision loss in immunocompetent people as well as immunocompromised |
|||
** 25% of cases are bilateral |
|||
=== Encephalitis === |
|||
== Diagnosis == |
== Diagnosis == |
Revision as of 21:24, 16 October 2019
- Comprises herpes simplex virus 1 (HSV-1) and HSV-2, which are members of the Human herpesvirus family
- Cause typical painful vesicular lesions on labia or external genitals
- Occasionally cause a viral encephalitis
Background
Microbiology
- Enveloped, double-stranded DNA virus
- HSV-1 and HSV-2 are morphologically and genetically distinct viruses
- Can be infected with both
Epidemiology
- Worldwide distribution, and only found in humans
- Most common cause of genital lesions
- Spread through person-to-person contact with skin or mucosa; not spread via fomits
- HSV-1 is more common, with 90% of adults having antibodies by age 40
- Often acquired in childhood in Asia and Africa
- More common in lower SES populations
- HSV-2 has seroprevalence of 15-20% in US
- More common in women than men, in HIV-infected people, and in MSM
- May be subclinical if already infected with HSV-1
Pathophysiology
- Fusion of envelope and cell membrane is mediated by viral glycoproteins B, C, and D and host cell proteins cellular heparin sulfate, TNF receptors, and immunoglobulins
- Internal capsid is released, which makes its way to the nucleus
- Viral DNA polymerase enzyme and viral DNA helicase are targets of antivirals
- Viral DNA may remain latent in about 10% of nearby neurons, characterized by latency-associated transcripts (LATs)
- Despite being latent, virus can still be shed in mucosa anywhere from 1/10 to 3/4 of days
- HSV-1 prefers trigeminal ganglia as well as cervical ganglia, or sacral nerve root ganglia if genital
Clinical Presentation
Primary infection
- Incubation period usually within 5 days for primary infection
- Mucocutaneous lesiosn may become secondarily infected
Orofacial infection
- Most common sites of primary infection are gingivostomatitis and pharyngitis
- Includes lesions on hard and soft palate, gingiva, tongue, lips, and face
- Pharyngeal lesions may be exudative or ulcerative
- May also have malaise, myalgias, anorexia or odynophagia, and cervical lymphadenopathy
- Self-resolving after 3 to 14 days
- Can cause a Bell palsy
Genital infection
- Genital lesions typically last 10 to 12 days, especially with first episode
- Often widely spaced bilateral lesions
- First episode often also involves fever, headache, malaise, and myalgias
- May have pain, itching, dysuria, genital discharge, and inguinal lymphadenopathy
- May develop extragenital sites of infection, including buttock, groin, and thigh with HSV-2 and perioral area with HSV-1
- Rarely fingers and eyes
- Develop around 14 days into the disease, likely from autoinoculation
- HSV-2 genital infections are less severe if the person has had HSV-1
- 12-month recurrence rate is up to 90% for HSV-2 and 55% for HSV-1
Neurological complications
- These can include aseptic meningitis, transverse myelitis, and sacral radiculopathy
- Typically occur in conjunction with first episode of genital HSV-2 infection
- Aseptic meningitis
- Mengitis is more common with HSV-2 than HSV-1
- Often concurrent with primary genital infection, typically 3 to 12 days after start of symptoms
- HSV-2 may also cause Mollaret's meningitis (benign recurrent lymphocytic meningitis)
- Autonomic dysfunction
- May have hyperesthesia or anaesthesia of perineum, lumbar or sacrum, as well as urinary retention and constipation
- Resolves over 4 to 8 weeks
- Transverse myelitis
- Decreased strength and deep tendon reflexes in lower extremities in conjunction with autonomic dysfunction (as above)
Pelvic inflammatory disease
- Rare cause of PID, possibly representing dual infection with a typical bacterial copathogen
Disseminated disease
- Rarely can disseminate
- Can be cutaneous, with concurrent meningitis, hepatitis, and pneumonitis
- Can also involve monocular arthritis, thrombocytopenia, adrenal necrosis, and myoglobinuria
- Patient factors include primary genital HSV in pregnancy, reactivation of genital HSV in a patient with cellular immunocompromise
Reactivation
- Typically localized to a single mucocutaneous area
- Symptoms are usually more minor than first-episode or primary infection, and include itching and pain
- Lesions may be atypical, with fissures and unusual ulcers
- May be subclinical, with intermittent viral shedding
- May be preceded by a prodrome of tingling up to 2 days
- Average duration of an episode of reactivation orolabial herpes is 5 days
- HSV-1 reactivates more frequently around mouth, and HSV-2 in genitals
- Frequency
- HSV-2 reactivates on average 4 to 5 times annually, with a gradual decrease over time
Herpetic whitlow
- HSV infection of the finger, with acute onset swelling, pain, and tenderness with vesicles
- Also fever and regional lymphadenopathy
- Can be either acquired from parson-to-person exposure or through autoinoculation
- Higher rates in healtcare settins
Herpes gladiatorum
- Herpes simplex infection essentially anywhere on the body (chest, ears, face, and hands) associated with wrestling
Ocular herpes
- Keratitis, which presents with pain, blurred vision, chemosis, conjunctivitis, and corneal lesions
- May also cause blepharitis and conjunctivitis
- May cause chorioretinitis in infants and immunocompromised
- Acute necrotizing retinitis
- Presents with painless vision loss in immunocompetent people as well as immunocompromised
- 25% of cases are bilateral
Encephalitis
Diagnosis
Management
References
- a b M. Howard, J. W. Sellors, D. Jang, N. J. Robinson, M. Fearon, J. Kaczorowski, M. Chernesky. Regional Distribution of Antibodies to Herpes Simplex Virus Type 1 (HSV-1) and HSV-2 in Men and Women in Ontario, Canada. Journal of Clinical Microbiology. 2003;41(1):84-89. doi:10.1128/jcm.41.1.84-89.2003.